The frequent dysregulation of THBS2 in several cancers [20] implies that it is not a specific marker for PDAC or dCCA, and it has been proposed as a diagnostic marker in colorectal cancer [21], hepatocellular cancer [22] and lung cancer [23]. This evidence concerns the gene THBS2 and lung cancer.